Income Statement ValiRx plc

Stocks

VAL

GB00BLH13C52

Biotechnology & Medical Research

Delayed London S.E. 11:35:02 2026-08-28 EDT			5-day change	1st Jan Change
0.1550 ^GBX	0.00%		0.00%	-53.73%

08-10	ValiRx subsidiary Cytolytix nears "significant" European patent win	AN
08-10	ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide	MT

a5b5.I8JiQAlC-mH2hYCrSK9dKilkkqFrtkVwYCbpJ087HwE.VfszCT0rviaf1MvOJfk1ZBES18cH7HUBCHGPbD9Ya3V7tlUMUS2JCoDm5w

Published financial data: VALIRX PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Revenues	-	-	9.6K	49.78K	31.37K
Total Revenues	-	-	9.6K	49.78K	31.37K
Cost of Goods Sold, Total	-	-	1.44K	-	37.62K
Gross Profit	-	-	8.16K	49.78K	-6.25K
Selling General & Admin Expenses, Total	1.22M	1.5M	1.89M	1.98M	1.59M
Provision for Bad Debts	-	-	-	-	-
Stock-Based Compensation (IS)	185K	540K	36.94K	-	-
R&D Expenses	304K	551K	383K	245K	229K
Other Operating Expenses	-26.95K	-	-	-30K	-
Other Operating Expenses, Total	1.68M	2.59M	2.31M	2.19M	1.82M
Operating Income	-1.68M	-2.59M	-2.3M	-2.14M	-1.82M
Interest Expense, Total	-2.76K	-5.46K	-4.42K	-1.28K	-3.33K
Interest And Investment Income	-	-	-	12.5K	8.48K
Net Interest Expenses	-2.76K	-5.46K	-4.42K	11.22K	5.15K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-1.68M	-2.6M	-2.3M	-2.13M	-1.82M
Impairment of Goodwill	-	-	-	-	-598K
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-1.68M	-2.6M	-2.3M	-2.13M	-2.42M
Income Tax Expense	-133K	-193K	-175K	-128K	-126K
Earnings From Continuing Operations	-1.55M	-2.41M	-2.13M	-2M	-2.29M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-1.55M	-2.41M	-2.13M	-2M	-2.29M
Minority Interest	28.98K	39.68K	90.08K	87.07K	56.82K
Net Income - (IS)	-1.52M	-2.37M	-2.04M	-1.92M	-2.23M
Net Income to Common Incl Extra Items	-1.52M	-2.37M	-2.04M	-1.92M	-2.23M
Net Income to Common Excl. Extra Items	-1.52M	-2.37M	-2.04M	-1.92M	-2.23M
Per Share Items
Net EPS - Basic	-0.02	-0.03	-0.02	-0.01	-0.01
Basic EPS - Continuing Operations	-0.02	-0.03	-0.02	-0.01	-0.01
Basic Weighted Average Shares Outstanding	65M	77.3M	102M	132M	414M
Net EPS - Diluted	-0.02	-0.03	-0.02	-0.01	-0.01
Diluted EPS - Continuing Operations	-0.02	-0.03	-0.02	-0.01	-0.01
Diluted Weighted Average Shares Outstanding	65M	77.3M	102M	132M	414M
Normalized Basic EPS	-0.02	-0.02	-0.01	-0.01	-0
Normalized Diluted EPS	-0.02	-0.02	-0.01	-0.01	-0
Supplemental Items
EBITDA	-1.46M	-2.39M	-2.05M	-1.87M	-1.59M
EBITA	-1.46M	-2.39M	-2.1M	-1.95M	-1.67M
EBIT	-1.68M	-2.59M	-2.3M	-2.14M	-1.82M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	7.94	7.41	7.61	5.99	5.23
Current Domestic Taxes	-133K	-193K	-175K	-128K	-126K
Total Current Taxes	-133K	-193K	-175K	-128K	-126K
Normalized Net Income	-1.02M	-1.58M	-1.35M	-1.24M	-1.08M
Interest on Long-Term Debt	1.38K	1.24K	1.09K	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	1.22M	1.5M	1.89M	1.98M	1.59M
Research And Development Expense From Footnotes	304K	551K	383K	245K	229K
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	185K	540K	36.94K	-	-
Total Stock-Based Compensation	185K	540K	36.94K	-	-

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Assets
Cash And Equivalents	594K	1.14M	175K	1.56M	792K
Total Cash And Short Term Investments	594K	1.14M	175K	1.56M	792K
Accounts Receivable, Total	-	-	-	42.35K	-
Other Receivables	165K	263K	244K	195K	184K
Total Receivables	165K	263K	244K	238K	184K
Inventory	-	-	69K	69K	69K
Prepaid Expenses	39.41K	61.52K	79.06K	34.28K	41.66K
Other Current Assets, Total	1.5K	1.5K	-	-	-
Total Current Assets	800K	1.46M	566K	1.9M	1.09M
Gross Property Plant And Equipment	54.82K	54.82K	346K	361K	375K
Accumulated Depreciation	-41.54K	-49.26K	-103K	-159K	-245K
Net Property Plant And Equipment	13.28K	5.56K	243K	202K	130K
Long-term Investments	-	-	-	30K	30K
Goodwill	1.6M	1.6M	1.6M	1.6M	1M
Other Intangibles, Total	1.11M	904K	719K	531K	381K
Total Assets	3.52M	3.98M	3.13M	4.26M	2.63M
Liabilities
Accounts Payable, Total	13.06K	24.96K	125K	148K	129K
Accrued Expenses, Total	34.89K	84.07K	76.92K	187K	105K
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	9.63K	9.96K	10.21K	10.47K	1.4K
Current Portion of Leases	7.76K	5.68K	-	-	-
Current Income Taxes Payable	-	-	-	-	-
Other Current Liabilities	2.89K	2.9K	2.88K	34	-
Total Current Liabilities	68.22K	128K	215K	345K	235K
Long-Term Debt	35.65K	22.07K	11.86K	1.39K	-
Long-Term Leases	5.68K	-	-	-	-
Total Liabilities	110K	150K	227K	346K	235K
Common Stock, Total	65.05K	90.17K	102K	374K	743K
Additional Paid In Capital	24.49M	26.77M	27.87M	30.61M	30.99M
Retained Earnings	-32.29M	-34.64M	-36.68M	-38.49M	-40.61M
Comprehensive Income and Other	11.34M	11.83M	11.93M	11.82M	11.73M
Total Common Equity	3.6M	4.05M	3.22M	4.32M	2.86M
Minority Interest	-185K	-225K	-315K	-402K	-459K
Total Equity	3.41M	3.83M	2.9M	3.92M	2.4M
Total Liabilities And Equity	3.52M	3.98M	3.13M	4.26M	2.63M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	65.05M	90.17M	102M	374M	743M
ECS Total Common Shares Outstanding	65.05M	90.17M	102M	374M	743M
Book Value / Share	0.06	0.04	0.03	0.01	0
Tangible Book Value	889K	1.54M	897K	2.18M	1.47M
Tangible Book Value Per Share	0.01	0.02	0.01	0.01	0
Total Debt	58.72K	37.71K	22.07K	11.86K	1.4K
Net Debt	-535K	-1.1M	-153K	-1.54M	-790K
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-185K	-225K	-315K	-402K	-459K
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	31.67K	31.67K	323K	361K	375K
Full Time Employees	7	8	16	14	11

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Net Income	-1.52M	-2.37M	-2.04M	-1.92M	-2.23M
Depreciation & Amortization - CF	7.72K	7.72K	54.12K	79.12K	85.57K
Amortization of Goodwill and Intangible Assets - (CF)	221K	204K	200K	188K	149K
Depreciation & Amortization, Total	229K	212K	254K	267K	235K
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	185K	540K	36.94K	-	-
Other Operating Activities, Total	-89.06K	-97.69K	-71.49K	-79.3K	487K
Change In Accounts Receivable	-6.19K	-60.89K	-13.8K	13.03K	-
Change In Inventories	-	-	-69K	-	-
Change In Accounts Payable	-60.51K	61.1K	129K	130K	-
Cash from Operations	-1.26M	-1.71M	-1.77M	-1.58M	-1.51M
Capital Expenditure	-	-	-291K	-38.16K	-13.58K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-15K	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-	-	-306K	-38.16K	-13.58K
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-14.32K	-22.25K	-16.74K	-10.21K	-10.47K
Total Debt Repaid	-14.32K	-22.25K	-16.74K	-10.21K	-10.47K
Issuance of Common Stock	21.67K	2.49M	1.3M	3.37M	921K
Other Financing Activities, Total	-	-209K	-168K	-360K	-151K
Cash from Financing	7.34K	2.26M	1.12M	3M	759K
Net Change in Cash	-1.25M	544K	-963K	1.38M	-764K
Supplemental Items
Cash Interest Paid	782	4.22K	3.32K	1.28K	3.33K
Cash Income Tax Paid (Refund)	-	-	-	-	-
Levered Free Cash Flow	-766K	-932K	-1.43M	-930K	-974K
Unlevered Free Cash Flow	-764K	-928K	-1.42M	-929K	-972K
Change In Net Working Capital	129K	59.05K	-27.2K	-181K	54.2K
Net Debt Issued / Repaid	-14.32K	-22.25K	-16.74K	-10.21K	-10.47K

Fiscal Period: December	2021 (GBP)	2022 (GBP)	2023 (GBP)	2024 (GBP)	2025 (GBP)
Profitability
Return on Assets	-24.79	-43.22	-40.43	-36.21	-33.05
Return on Total Capital	-25.27	-44.18	-42.31	-39.06	-36.01
Return On Equity %	-37.88	-66.46	-63.23	-58.74	-72.53
Return on Common Equity	-35.68	-61.87	-56.06	-50.84	-62.24
Margin Analysis
Gross Profit Margin %	-	-	85	100	-19.92
SG&A Margin	-	-	19.65K	3.97K	5.06K
EBITDA Margin %	-	-	-21.35K	-3.77K	-5.06K
EBITA Margin %	-	-	-21.86K	-3.93K	-5.33K
EBIT Margin %	-	-	-23.94K	-4.3K	-5.81K
Income From Continuing Operations Margin %	-	-	-22.16K	-4.02K	-7.3K
Net Income Margin %	-	-	-21.23K	-3.85K	-7.12K
Net Avail. For Common Margin %	-	-	-21.23K	-3.85K	-7.12K
Normalized Net Income Margin	-	-	-14.05K	-2.5K	-3.44K
Levered Free Cash Flow Margin	-	-	-14.87K	-1.87K	-3.1K
Unlevered Free Cash Flow Margin	-	-	-14.84K	-1.87K	-3.1K
Asset Turnover
Asset Turnover	-	-	0	0.01	0.01
Fixed Assets Turnover	-	-	0.08	0.22	0.19
Inventory Turnover (Average Inventory)	-	-	-	-	0.55
Short Term Liquidity
Current Ratio	11.73	11.48	2.64	5.5	4.62
Quick Ratio	11.13	10.98	1.95	5.2	4.15
Operating Cash Flow to Current Liabilities	-18.48	-13.42	-8.26	-4.59	-6.42
Days Outstanding Inventory (Average Inventory)	-	-	-	-	669.44
Average Days Payable Outstanding	-	-	-	-	1.34K
Long Term Solvency
Total Debt/Equity	1.72	0.99	0.76	0.3	0.06
Total Debt / Total Capital	1.69	0.98	0.75	0.3	0.06
LT Debt/Equity	1.21	0.58	0.41	0.04	-
Long-Term Debt / Total Capital	1.19	0.57	0.41	0.04	-
Total Liabilities / Total Assets	3.11	3.76	7.24	8.13	8.93
EBIT / Interest Expense	-606.81	-475.33	-520.15	-1.67K	-547.62
EBITDA / Interest Expense	-524.07	-436.48	-462.62	-1.47K	-477
(EBITDA - Capex) / Interest Expense	-524.07	-436.48	-528.52	-1.5K	-481.08
Total Debt / EBITDA	-0.04	-0.02	-0.01	-0.01	-0
Net Debt / EBITDA	0.37	0.46	0.07	0.82	0.5
Total Debt / (EBITDA - Capex)	-0.04	-0.02	-0.01	-0.01	-0
Net Debt / (EBITDA - Capex)	0.37	0.46	0.07	0.81	0.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	418.49	-36.97
Gross Profit, 1 Yr. Growth %	-	-	-	509.99	-52.27
EBITDA, 1 Yr. Growth %	2.35	64	-14.2	-8.55	-15.32
EBITA, 1 Yr. Growth %	2.35	64	-12.17	-6.89	-14.37
EBIT, 1 Yr. Growth %	1.65	54.57	-11.37	-6.82	-14.9
Earnings From Cont. Operations, 1 Yr. Growth %	5.37	55.52	-11.57	-5.88	14.29
Net Income, 1 Yr. Growth %	5.19	55.87	-13.89	-5.99	16.52
Normalized Net Income, 1 Yr. Growth %	0.54	55.14	-14.85	-7.77	-13.3
Diluted EPS Before Extra, 1 Yr. Growth %	-38.67	31.08	-34.47	-27.54	-62.87
Inventory, 1 Yr. Growth %	-	-	-	0	0
Net Property, Plant and Equip., 1 Yr. Growth %	-36.76	-58.12	4.26K	-16.88	-35.7
Total Assets, 1 Yr. Growth %	-28.63	12.83	-21.27	36.15	-38.26
Tangible Book Value, 1 Yr. Growth %	-55.11	73.8	-41.91	143.41	-32.73
Common Equity, 1 Yr. Growth %	-26.71	12.55	-20.55	34.14	-33.87
Cash From Operations, 1 Yr. Growth %	-34.03	35.83	3.51	-10.58	-4.71
Capital Expenditures, 1 Yr. Growth %	-	-	-	-86.9	-64.41
Levered Free Cash Flow, 1 Yr. Growth %	-55.6	21.66	53.2	-34.87	4.76
Unlevered Free Cash Flow, 1 Yr. Growth %	-55.59	21.49	53.46	-34.79	4.63
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	-	80.77
Gross Profit, 2 Yr. CAGR %	-	-	-	-	-12.48
EBITDA, 2 Yr. CAGR %	-23.9	29.56	18.62	-11.42	-12
EBITA, 2 Yr. CAGR %	-23.9	29.56	20.02	-9.57	-10.71
EBIT, 2 Yr. CAGR %	-21.15	25.35	17.04	-9.13	-10.96
Earnings From Cont. Operations, 2 Yr. CAGR %	-20.14	28.01	17.27	-8.77	3.72
Net Income, 2 Yr. CAGR %	-20.28	28.05	15.85	-10.03	4.66
Normalized Net Income, 2 Yr. CAGR %	-21.62	24.89	14.93	-11.38	-10.57
Diluted EPS Before Extra, 2 Yr. CAGR %	-73.43	-10.34	-7.32	-31.09	-48.13
Inventory, 2 Yr. CAGR %	-	-	-	-	0
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-48.53	327.47	502.19	-26.89
Total Assets, 2 Yr. CAGR %	-1.13	-10.27	-5.75	3.54	-8.31
Tangible Book Value, 2 Yr. CAGR %	1.13	-11.67	0.48	18.91	27.96
Common Equity, 2 Yr. CAGR %	23.65	-9.18	-5.44	3.24	-5.82
Cash From Operations, 2 Yr. CAGR %	-3.07	-5.34	18.57	-3.79	-7.69
Capital Expenditures, 2 Yr. CAGR %	-	-	-	-	-78.4
Levered Free Cash Flow, 2 Yr. CAGR %	-18.2	-26.5	36.52	-0.11	-17.39
Unlevered Free Cash Flow, 2 Yr. CAGR %	-18.22	-26.55	36.54	0.03	-17.4
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-29.9	-1.7	12.93	8.77	-12.74
EBITA, 3 Yr. CAGR %	-29.9	-1.7	13.82	10.28	-11.2
EBIT, 3 Yr. CAGR %	-27.33	-1.31	11.67	8.48	-11.09
Earnings From Cont. Operations, 3 Yr. CAGR %	-29.24	-0.27	13.16	8.98	-1.65
Net Income, 3 Yr. CAGR %	-29.32	-0.31	12.18	8.06	-1.93
Normalized Net Income, 3 Yr. CAGR %	-29.77	-1.59	9.92	6.81	-12.02
Diluted EPS Before Extra, 3 Yr. CAGR %	-72.88	-54.77	-19.24	-14.62	-43.93
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	126.09	147.65	185.69
Total Assets, 3 Yr. CAGR %	-5.94	3.32	-14.09	6.54	-12.85
Tangible Book Value, 3 Yr. CAGR %	105.92	21.14	-23.18	34.95	-1.65
Common Equity, 3 Yr. CAGR %	4.83	19.84	-13.14	6.25	-11.01
Cash From Operations, 3 Yr. CAGR %	-27.83	8.47	-2.47	7.93	-4.1
Levered Free Cash Flow, 3 Yr. CAGR %	-29.89	-6.63	-6.11	6.68	1.49
Unlevered Free Cash Flow, 3 Yr. CAGR %	-29.94	-6.69	-6.1	6.73	1.54
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-18.56	-4.05	-13.48	-5.71	2.21
EBITA, 5 Yr. CAGR %	-18.6	-4.12	-13.08	-4.93	3.29
EBIT, 5 Yr. CAGR %	-16.65	-3.66	-12.07	-4.52	2
Earnings From Cont. Operations, 5 Yr. CAGR %	-21.32	-5.17	-13.4	-3.76	9.29
Net Income, 5 Yr. CAGR %	-20.39	-4.76	-13.87	-4.32	9.11
Normalized Net Income, 5 Yr. CAGR %	-21.35	-5.51	-14.48	-5.63	1.21
Diluted EPS Before Extra, 5 Yr. CAGR %	-70.62	-58.54	-55.67	-46.47	-32.35
Net Property, Plant and Equip., 5 Yr. CAGR %	4.7	-	-	-	43.93
Total Assets, 5 Yr. CAGR %	-6.62	-4.24	-5.86	3.41	-11.83
Tangible Book Value, 5 Yr. CAGR %	13.36	43.98	54.55	20.24	-5.79
Common Equity, 5 Yr. CAGR %	8.9	4.98	0.59	12.9	-10.28
Cash From Operations, 5 Yr. CAGR %	-21.38	-6.15	-11.97	3.39	-4.6
Levered Free Cash Flow, 5 Yr. CAGR %	-12.53	-13.65	-8.47	-4.07	-10.8
Unlevered Free Cash Flow, 5 Yr. CAGR %	-9.86	-10.97	-8.5	-4.06	-10.79